Rick Gerson
Co-Founder, Chairman & Chief Investment Officer @ Alpha Wave Incubation
Miami, United States
Rick Gerson is a Series B investor at Alpha Wave Incubation in Miami focused on Health Care and Biotechnology. Rick Gerson is the Co-Founder, Chairman and Chief Investment Officer of Alpha Wave, a global investment management company focused on three main verticals: private equity, private credit, and public markets. Some of Alpha Wave's investments include SpaceX, Aman Group, Athletic Greens, Apnimed, COUR Pharmaceuticals, OfBusiness, and Lenskart.Prior to founding Alpha Wave, Rick was a Founding Member and Managing Director of Blue Ridge Capital, a global investment firm started in 1996, where he was from inception for 15 years.Rick serves on the board of directors of Aman Group, Athletic Greens, Arena Events Group, Multiply Group, African Mission Healthcare, 92nd Street Y. He is also a co-founder and serves on the board of Abu Dhabi Catalyst Partners.Rick is a member of the Cleveland Clinic International Leadership Board, a founding member of the Board of Trustees of the PAVE charter school in Brooklyn, a member of the Panthera Conservation Council, and a member of the Belfer Center's International Council at the John F. Kennedy School of Government at Harvard University.Rick graduated from the University of Virginia, McIntire School of Commerce with a B.S. in Commerce with a concentration in Finance.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 79%
Last updated:
For AI agents: llms.txt
Industries Rick Gerson invests in
Stages Rick Gerson invests in
Countries Rick Gerson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (13%)
- Biotechnology 3 (13%)
- SaaS 2 (8%)
- FinTech 2 (8%)
- Software 2 (8%)
Stage
- Series B 3 (13%)
- Series C 3 (13%)
- Funding Round 3 (13%)
- Series A 2 (8%)
- Private Equity 2 (8%)
Country
- United States 10 (42%)
- India 3 (13%)
- Israel 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Moonwalk Biosciences
|
Moonwalk Biosciences is a genomic medicine startup that aims to provide a new class of precision epigenetic therapeutics. The company is working on the development of a profiling and engineering technology platform that, with the help of advanced artificial intelligence prediction, provides a comprehensive view of the epigenome in health anddisease, allowing healthcare providers to take a fresh look at how therapies are discovered and developed. | $70M / Series B / Sep 08, 2026 | |
Nxtra Data
|
The connected economy is dotted with disruptive trends. Every year they see traditional business models being modified with newer revenue streams and infrastructure. Business processes and operations continuously seek higher agility and efficiency. Riding the next wave of customer experience has become a top priority. Nxtra believes that thiscompetitive environment provides a perfect opportunity to bring technology from the edges to the core of business strategy. That’s why they offer a smart, secure, and reliable approach to leading innovation and embracing disruption with their cloud managed services. As a fully owned subsidiary of Bharti Airtel, they support leading enterprises, SMBs, global customers and government institutions in India with their datacenter services. With 1,98,000 sq. ft. of data center space, they offer an integrated and award-winning portfolio of colocation services, along with cloud infrastructure, managed hosting, data backup, disaster recovery, and remote infrastructure management. Relying on globally benchmarked service delivery models and assurance processes, they meet your specific business requirements and SLAs. | $1B / Private Equity / Mar 30, 2026 | |
Cerebras Systems
|
Cerebras Systems is a startup backed by premier venture capitalists and the industry’s most successful technologists. They are serially successful entrepreneurs dedicated to solving problems others are afraid to tackle. They value integrity, passion, real world problem solving ability, and a sense of humor. | $1B / Series H / Feb 04, 2026 | |
|
Cerebras Systems
|
Cerebras Systems is a startup backed by premier venture capitalists and the industry’s most successful technologists. They are serially successful entrepreneurs dedicated to solving problems others are afraid to tackle. They value integrity, passion, real world problem solving ability, and a sense of humor. | $1.1B / Series G / Sep 30, 2025 | |
Biolinq
|
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $100M / Series C / Mar 19, 2025 | |
Haldiram Snacks
|
Haldiram is a company that sells Indian snacks and sweets. They have been in business for over 80 years and have a wide variety of products, including sweets, savouries, tea snacks, and instant food. | $1.6B / Mar 11, 2025 | |
ZEDEDA
|
ZEDEDA is a provider of distributed edge orchestration and virtualization software. It focused on edge virtualization to deliver visibility, control, and protection for distributed edge gateways, applications, and networks at the enterprise edge as a cloud-based service. It was founded in 2016 and is based in San Jose, California, United States. | Venture - Series Unknown / Jan 16, 2025 | |
Mitra Chem
|
Mitra Chem operates as a lithium-ion battery materials manufacturer. It innovates and commercializes iron-based cathode materials to enable mass-market electrification in transportation and energy storage. The company is driven to industrialize these cathodes in purpose-built inflation reduction act-compliant facilities. | Series B / May 13, 2024 | |
|
Biolinq
|
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $58M / Venture - Series Unknown / Apr 04, 2024 | |
|
Biolinq
|
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $58M / Series D / Apr 04, 2024 | |
| See all 24 investments → | |||
Co-Investors
About Alpha Wave Incubation
Alpha Wave Incubation an early-stage $300 million fund managed by Alpha Wave Global cofounder Navroz Udwadia.
Alpha Wave Incubation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Rick Gerson
Co-Founder, Chairman & Chief Investment Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Rick Gerson invest in?
Rick Gerson invests primarily in Health Care, Biotechnology and SaaS startups, most often at Series B and Series C stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Rick Gerson?
Public channels for Rick Gerson include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Rick Gerson last invest?
The most recent investment recorded for Rick Gerson closed in Sep 2026. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
